Objectives <p>Despite significant potential adverse health outcomes, many cancer survivors continue smoking. Few smoking cessation interventions have demonstrated efficacy above standard treatment for this population. Through a rigorous iterative process, we developed a prototype smartphone app that addresses both general and cancer-specific relapse risks in real time, incorporating cancer survivors’ feedback. We report findings from two studies: (1) Qualitative interviews and brief surveys to inform intervention development and (2) Usability testing of the prototype app in a 4-week single-arm pilot trial.</p> Method <p>Cancer survivors (Study 1: <i>n</i> = 20; Study 2: <i>n</i> = 12) who had smoked at least one cigarette within the past 30&#xa0;days were enrolled. Study 1 participants completed a 50-minutes Zoom interview and survey to inform intervention content and the app design. Subsequently, a prototype app was developed and tested for usability in Study 2, which included ecological momentary interventions (EMIs), three telehealth counseling sessions, and nicotine patches. Baseline and end-of-treatment (EOT) surveys and interviews were completed.</p> Results <p>Key findings in Study 1 included high perceived helpfulness of mindfulness and EMIs for managing cravings and cancer-related stress, and a reported strong willingness to use the app. In Study 2, eleven participants used the app and completed counseling sessions. Participants reported high treatment acceptability, app usability, and ease of use. A key suggested improvement was adjusting the timing of app notifications.</p> Conclusions <p>Results support continued investigation of this app. Next steps include testing the feasibility and acceptability of the app for smoking cessation.</p> Preregistration <p>Study 2 is registered in ClinicalTrials.gov (NCT06476548).</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Mindfulness-Based Ecological Momentary Intervention for Smoking Cessation to Address Cancer-Related Relapse Risk Factors: Intervention Development and Usability Findings

  • Min-Jeong Yang,
  • Steven K. Sutton,
  • Cherell Cottrell-Daniels,
  • Lee M. Ritterband,
  • Rebecca Blackwell,
  • Melinda Leigh Maconi,
  • Ranjita Poudel,
  • Smitha Pabbathi,
  • Vani N. Simmons,
  • Christine Vinci

摘要

Objectives

Despite significant potential adverse health outcomes, many cancer survivors continue smoking. Few smoking cessation interventions have demonstrated efficacy above standard treatment for this population. Through a rigorous iterative process, we developed a prototype smartphone app that addresses both general and cancer-specific relapse risks in real time, incorporating cancer survivors’ feedback. We report findings from two studies: (1) Qualitative interviews and brief surveys to inform intervention development and (2) Usability testing of the prototype app in a 4-week single-arm pilot trial.

Method

Cancer survivors (Study 1: n = 20; Study 2: n = 12) who had smoked at least one cigarette within the past 30 days were enrolled. Study 1 participants completed a 50-minutes Zoom interview and survey to inform intervention content and the app design. Subsequently, a prototype app was developed and tested for usability in Study 2, which included ecological momentary interventions (EMIs), three telehealth counseling sessions, and nicotine patches. Baseline and end-of-treatment (EOT) surveys and interviews were completed.

Results

Key findings in Study 1 included high perceived helpfulness of mindfulness and EMIs for managing cravings and cancer-related stress, and a reported strong willingness to use the app. In Study 2, eleven participants used the app and completed counseling sessions. Participants reported high treatment acceptability, app usability, and ease of use. A key suggested improvement was adjusting the timing of app notifications.

Conclusions

Results support continued investigation of this app. Next steps include testing the feasibility and acceptability of the app for smoking cessation.

Preregistration

Study 2 is registered in ClinicalTrials.gov (NCT06476548).